The dorsal periaqueductal gray modulates the increased fear-like behavior exhibited by experienced rats in the elevated plus-maze

Behavioural Brain Research

Volumn 206, Issue 1, 2010, Pages 120-126

  Kincheski, Grasielle C ^a   Carobrez, Antonio P ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Anxiety; Elevated plus maze; Fear; NMDA receptor antagonist; Periaqueductal gray; Step down inhibitory avoidance task

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVOIDANCE BEHAVIOR; BRAIN FUNCTION; CONTROLLED STUDY; FEAR; MALE; MAZE TEST; NEUROMODULATION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; CATHETERS, INDWELLING; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; EXPLORATORY BEHAVIOR; FEAR; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; PERIAQUEDUCTAL GRAY; PIPERIDINES; RATS; RATS, WISTAR; SPACE PERCEPTION; STAINING AND LABELING; VALINE;

EID: 70350200858     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.09.001     Document Type: Article

References (48)

1. Adams D.B. Brain mechanisms for offense, defense and submission. Behav Brain Sci 2 (1979) 201-241
2. Adams D.B. Brain mechanisms of aggressive behavior: an updated (Review). Neurosci Biobehav Rev 30 (2006) 304-318
3. Albrechet-Souza L., Borelli K.G., and Brandão M.L. Activity of the medial prefrontal cortex and amygdala underlies one-trial tolerance of rats in the elevated plus-maze. J Neurosci Methods 169 1 (2008) 109-118
4. Bandler R., Carrive P., and Depaulis A. Introduction-emerging principles of organization of the midbrain periaqueductal gray matter. In: Depaulis A., and Bandler R. (Eds). The midbrain periaqueductal gray matter (1991), Plenum Press, New York 1-8
5. Bandler R., and Depaulis A. Elicitation of intraspecific defence reactions in the rat from midbrain periaqueductal grey by microinjection of kainic acid, without neurotoxic effects. Neurosci Lett 88 3 (1988) 291-296
6. Batista-da-Silva A.P., Rae G.A., and Carobrez A.P. Microinjection of D-2-amino-7 phosphonoheptanoate into the dorsal periaqueductal gray matter reduces the pressor response to glutamate injected at the same site. Braz J Med Biol Res 23 8 (1990) 705-708
7. Beckett S.R., Lawrence A.J., Marsden C.A., and Marshall P.W. Attenuation of chemically induced defence response by 5-HT1 receptor agonists administered into the periaqueductal gray. Psychopharmacology 108 (1992) 110-114
8. Bertoglio L.J., Anzini C., Lino-de-Oliveira C., and Carobrez A.P. Enhanced dorsolateral periaqueductal gray activity counteracts the anxiolytic response to midazolam on the elevated plus-maze trial 2 in rats. Behav Brain Res 162 (2005) 99-107
9. Bertoglio L.J., and Carobrez A.P. Previous maze experience required to increase open arm avoidance in rats submitted to the elevated plus-maze model of anxiety. Behav Brain Rev 108 (2000) 197-203
10. Bertoglio L.J., and Carobrez A.P. Prior maze experience required to alter midazolam effects in rats submitted to the elevated plus-maze. Phamarcol Biochem Behav 72 (2002) 449-455
11. Bertoglio L.J., and Carobrez A.P. Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze trial 2 in rats. Psychopharmacology 170 (2003) 335-342
12. Brandão M.L., de Aguiar J.C., and Graeff F.G. GABA mediation of the anti-aversive action of minor tranquilizers. Pharmacol Biochem Behav 16 3 (1982) 397-402
13. Carobrez A.P., and Bertoglio L.J. Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev 29 (2005) 1193-1205
14. Carobrez A.P., Schenberg L.C., and Graeff F.G. Neuroeffector mechanisms of the defense reaction in the rat. Physiol Behav 31 4 (1983) 439-444
15. Carobrez A.P., Teixeira K.V., and Graeff F.G. Modulation of defensive behavior by periaqueductal gray NMDA/glycine-B receptor. Neurosci Biobehav Rev 25 (2001) 697-709
16. De Oca B.M., DeCola J.P., Maren S., and Fanselow M.S. Distinct regions of the periaqueductal gray are involved in the acquisition and expression of defensive responses. J Neurosci 18 9 (1998) 3426-3432
17. De-Souza M.M., Schenberg L.C., and Carobrez A.P. NMDA-coupled periaqueductal gray glycine receptors modulate anxioselective drug effects on plus-maze performance. Behav Brain Res 90 (1998) 157-165
18. File S.E. One-trial tolerance to the anxiolytic effect of chlordiazepoxide in the plus-maze. Psychopharmacology 100 (1990) 281-282
19. File S.E. The interplay of learning and anxiety in the elevated plus-maze. Behav Brain Res 58 (1993) 199-202
20. File S.E., Gonzalez L.E., and Gallant R. Role of the basolateral nucleus of the amygdala in the formation of a phobia. Neuropsychopharmacology 19 (1998) 397-405
21. File S.E., Gonzalez L.E., and Gallant R. Role of the dorsomedial hypothalamus in mediating the response to benzodiazepines on trial 2 in the elevated plus-maze test of anxiety. Neuropsychopharmacology 21 (1999) 312-320
22. File S.E., Mabbutt P.S., and Hitchott P.K. Characterization of phenomenon of 'one-trial tolerance' to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze. Psychopharmacology 102 (1990) 98-101
23. Gray A.J., and McNaughton N. The neuropsychology of anxiety. second ed. (2000), Oxford University Press, New York p. 72-82
24. Guimarães F.S., Carobrez A.P., De Aguiar J.C., and Graeff F.G. Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey. Psychopharmacology 103 (1991) 91-94
25. Hilton S.M. The defensive-arousal system and its relevance for circulatory and respiratory control. J Exp Biol 100 (1982) 159-174
26. Izquierdo I., Barros D.M., Mello e Souza T., de Souza M.M., Izquierdo L.A., and Medina J.H. Mechanisms for memory types differ. Nature 393 (1998) 635-636
27. Keay K.A., and Bandler R. Deep and superficial noxious stimulation increases Fos-like immunoreactivity in different regions of the midbrain periaqueductal grey of the rat. Neurosci Lett 154 1-2 (1993) 23-26
28. Kemble E.D., Blanchard D.C., Blanchard R.J., and Takushi R. Taming in wild rats following medial amygdaloid lesions. Physiol Behav 32 1 (1981) 131-134
29. Krieger J.E., and Graeff F.G. Defensive behavior and hypertension induced by glutamate in the midbrain central gray of the rat. Braz J Med Biol Res 18 1 (1985) 61-67
30. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92 (1987) 180-185
31. Lu C.L., Shaikh M.B., and Siegel A. Role ofNMDA receptors in hypothalamic facilitation of feline defensive rage elicited from the midbrain periaqueductal gray. Brain Res 581 (1992) 123-132
32. Matheus M.G., and Guimarães F.S. Antagonism of non-NMDA receptors in the dorsal periaqueductal grey induces anxiolytic effect in the elevated plus maze. Psychopharmacology (Berl) 132 1 (1997) 14-18
33. Molchanov M.L., and Guimarães F.S. Anxiolytic-like effects of AP7 injected into the dorsolateral or ventrolateral columns of the periaqueductal gray of rats. Psychopharmacology (Berl) 160 1 (2002) 30-38
34. Moraes C.L.K., Bertoglio L.J., and Carobrez A.P. Interplay between glutamate and serotonin within the dorsal periaqueductal gray modulates anxiety-related behavior of rats exposed to the elevated plus-maze. Behav Brain Res 194 (2008) 181-186
35. Moreira F.A., Molchanov M.L., and Guimarães F.S. Ionotropic glutamate-receptor antagonists inhibit the aversive effects of nitric oxide donor injected into the dorsolateral periaqueductal gray of rats. Psychopharmacology (Berl) 171 2 (2004) 199-203
36. Nascimento Häckl L.P., and Carobrez A.P. Distinct ventral and dorsal hippocampus AP5 anxiolytic effects revealed in the elevated plus-maze task in rats. Neurobiol Learn Mem 88 2 (2007) 177-185
37. Nashold Jr. B.S., Wilson W.P., and Slaughter D.G. Sensations evoked by stimulation in the midbrain of man. J Neurosurg 30 (1969) 14-24
38. Olds M.E., and Olds J. Approach-escape interactions in rat brain. Am J Physiol 203 (1962) 803-810
39. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 4th ed. (1998), Academic Press, New York
40. Rodgers R.J., and Shepherd J.K. Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice. Psychopharmacology 113 (1993) 237-242
41. Rodrigues S.M., Schafe G.E., and LeDoux J.E. Intra-amygdala blockade of the NR2B subunit of the NMDA receptor disrupts the acquisition but not the expression of fear conditioning. J Neurosci 21 17 (2001) 6889-6896
42. Roy V., Chapillon P., Jeljeli M., Caston J., and Belzung C. Free versus forced exposure to an elevated plus-maze: evidence for new behavioral interpretations during test and retest. Psychopharmacology 203 (2009) 131-141
43. Schenberg L.C., and Graeff F.G. Role of the periaqueductal gray substance in the antianxiety action of benzodiazepines. Pharmacol Biochem Behav 9 3 (1978) 287-295
44. Schmitt M.L., Coelho W., Lopes-de-Souza A.S., Guimaraes F.S., and Carobrez A.P. Anxiogenic-like effect of glycine and D-serine microinjected into dorsal periaqueductal gray matter of rats. Neurosci Lett 189 (1995) 93-96
45. Schmitt M.L., Graeff F.G., and Carobrez A.P. Anxiolytic effect of kynurenic acid microinjected into the dorsal periaqueductal gray matter of rats placed in the elevated plus-maze test. Braz J Med Biol Res 23 8 (1990) 677-679
46. Sukikara M.H., Mota-Ortiz S.R., Baldo M.V., Felício L.F., and Canteras N.S. A role for the periaqueductal gray in switching adaptive behavioral responses. J Neurosci 26 9 (2006) 2583-2589
47. Teixeira K.V., and Carobrez A.P. Effects of glycine or (±)-3-amino-1-hydroxy-2-pyrrolidone microinjections along the rostrocaudal axis of the dorsal periaqueductal gray matter on rats' performance in the elevated plus-maze task. Behav Neurosci 113 (1999) 196-203
48. Treit D., Menard J., and Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 44 (1993) 463-469